After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Phathom Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Phathom Pharmaceuticals Inc is $415.74M. A total of 1.03 million shares were traded on the day, compared to an average of 1.01M shares.
Insider Activity
Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PHAT has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Henderson Molly sold 6,583 shares of PHAT for 6.59 per share on Jan 21 ’25. After the transaction, the CFO and CBO now owns 93,546 company shares. In a previous transaction on Jan 21 ’25, Nabulsi Azmi sold 7,886 shares at 6.59 per share. PHAT shares that Chief Operating Officer owns now total 233,390.
Among the insiders who sold shares, Curran Terrie disposed of 19,109 shares on Jan 21 ’25 at a per-share price of $6.59. This resulted in the President and Chief Executive holding 360,465 shares of PHAT after the transaction. In another insider transaction, Nabulsi Azmi sold 1,118 shares at $8.00 per share on Dec 19 ’24. Company shares held by the Chief Operating Officer now total 239,303.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PHAT in the last 3 months, the mean price target is $24.63 with high estimates of $28.00 and low estimates of $17.00. In terms of 52-week highs and lows, PHAT has a high of $19.71 and a low of $5.07.
As of this writing, PHAT has an earnings estimate of -$1.08 per share for the current quarter. EPS was calculated based on a consensus of 4.0 estimates, with a high estimate of -$0.98 per share and a lower estimate of -$1.17.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PHAT’s latest balance sheet shows that the firm has $183.26M in Cash & Short Term Investments as of fiscal 2021. There were $91.34M in debt and $18.92M in liabilities at the time. Its Book Value Per Share was -$2.74, while its Total Shareholder’s Equity was $72.16M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PHAT is Buy with a score of 4.63.
